Cargando…

Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19

The etiologic mechanisms of post-acute medical morbidities and unexplained symptoms (Long COVID) following SARS-CoV-2 infection are incompletely understood. There is growing evidence that viral persistence and immune dysregulation may play a major role. We performed whole-body positron emission tomo...

Descripción completa

Detalles Bibliográficos
Autores principales: Peluso, Michael J., Ryder, Dylan, Flavell, Robert, Wang, Yingbing, Levi, Jelena, LaFranchi, Brian H., Deveau, Tyler-Marie, Buck, Amanda M., Munter, Sadie E., Asare, Kofi A., Aslam, Maya, Koch, Wally, Szabo, Gyula, Hoh, Rebecca, Deswal, Monika, Rodriguez, Antonio, Buitrago, Melissa, Tai, Viva, Shrestha, Uttam, Lu, Scott, Goldberg, Sarah A., Dalhuisen, Thomas, Durstenfeld, Matthew S., Hsue, Priscilla Y., Kelly, J. Daniel, Kumar, Nitasha, Martin, Jeffrey N., Gambir, Aruna, Somsouk, Ma, Seo, Youngho, Deeks, Steven G., Laszik, Zoltan G., VanBrocklin, Henry F., Henrich, Timothy J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418298/
https://www.ncbi.nlm.nih.gov/pubmed/37577714
http://dx.doi.org/10.1101/2023.07.27.23293177
_version_ 1785088229573132288
author Peluso, Michael J.
Ryder, Dylan
Flavell, Robert
Wang, Yingbing
Levi, Jelena
LaFranchi, Brian H.
Deveau, Tyler-Marie
Buck, Amanda M.
Munter, Sadie E.
Asare, Kofi A.
Aslam, Maya
Koch, Wally
Szabo, Gyula
Hoh, Rebecca
Deswal, Monika
Rodriguez, Antonio
Buitrago, Melissa
Tai, Viva
Shrestha, Uttam
Lu, Scott
Goldberg, Sarah A.
Dalhuisen, Thomas
Durstenfeld, Matthew S.
Hsue, Priscilla Y.
Kelly, J. Daniel
Kumar, Nitasha
Martin, Jeffrey N.
Gambir, Aruna
Somsouk, Ma
Seo, Youngho
Deeks, Steven G.
Laszik, Zoltan G.
VanBrocklin, Henry F.
Henrich, Timothy J.
author_facet Peluso, Michael J.
Ryder, Dylan
Flavell, Robert
Wang, Yingbing
Levi, Jelena
LaFranchi, Brian H.
Deveau, Tyler-Marie
Buck, Amanda M.
Munter, Sadie E.
Asare, Kofi A.
Aslam, Maya
Koch, Wally
Szabo, Gyula
Hoh, Rebecca
Deswal, Monika
Rodriguez, Antonio
Buitrago, Melissa
Tai, Viva
Shrestha, Uttam
Lu, Scott
Goldberg, Sarah A.
Dalhuisen, Thomas
Durstenfeld, Matthew S.
Hsue, Priscilla Y.
Kelly, J. Daniel
Kumar, Nitasha
Martin, Jeffrey N.
Gambir, Aruna
Somsouk, Ma
Seo, Youngho
Deeks, Steven G.
Laszik, Zoltan G.
VanBrocklin, Henry F.
Henrich, Timothy J.
author_sort Peluso, Michael J.
collection PubMed
description The etiologic mechanisms of post-acute medical morbidities and unexplained symptoms (Long COVID) following SARS-CoV-2 infection are incompletely understood. There is growing evidence that viral persistence and immune dysregulation may play a major role. We performed whole-body positron emission tomography (PET) imaging in a cohort of 24 participants at time points ranging from 27 to 910 days following acute SARS-CoV-2 infection using a novel radiopharmaceutical agent, [(18)F]F-AraG, a highly selective tracer that allows for anatomical quantitation of activated T lymphocytes. Tracer uptake in the post-acute COVID group, which included those with and without Long COVID symptoms, was significantly higher compared to pre-pandemic controls in many anatomical regions, including the brain stem, spinal cord, bone marrow, nasopharyngeal and hilar lymphoid tissue, cardiopulmonary tissues, and gut wall. Although T cell activation tended to be higher in participants imaged closer to the time of the acute illness, tracer uptake was increased in participants imaged up to 2.5 years following SARS-CoV-2 infection. We observed that T cell activation in spinal cord and gut wall was associated with the presence of Long COVID symptoms. In addition, tracer uptake in lung tissue was higher in those with persistent pulmonary symptoms. Notably, increased T cell activation in these tissues was also observed in many individuals without Long COVID. Given the high [(18)F]F-AraG uptake detected in the gut, we obtained colorectal tissue for in situ hybridization SARS-CoV-2 RNA and immunohistochemical studies in a subset of participants with Long COVID symptoms. We identified cellular SARS-CoV-2 RNA in rectosigmoid lamina propria tissue in all these participants, ranging from 158 to 676 days following initial COVID-19 illness, suggesting that tissue viral persistence could be associated with long-term immunological perturbations.
format Online
Article
Text
id pubmed-10418298
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-104182982023-08-12 Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19 Peluso, Michael J. Ryder, Dylan Flavell, Robert Wang, Yingbing Levi, Jelena LaFranchi, Brian H. Deveau, Tyler-Marie Buck, Amanda M. Munter, Sadie E. Asare, Kofi A. Aslam, Maya Koch, Wally Szabo, Gyula Hoh, Rebecca Deswal, Monika Rodriguez, Antonio Buitrago, Melissa Tai, Viva Shrestha, Uttam Lu, Scott Goldberg, Sarah A. Dalhuisen, Thomas Durstenfeld, Matthew S. Hsue, Priscilla Y. Kelly, J. Daniel Kumar, Nitasha Martin, Jeffrey N. Gambir, Aruna Somsouk, Ma Seo, Youngho Deeks, Steven G. Laszik, Zoltan G. VanBrocklin, Henry F. Henrich, Timothy J. medRxiv Article The etiologic mechanisms of post-acute medical morbidities and unexplained symptoms (Long COVID) following SARS-CoV-2 infection are incompletely understood. There is growing evidence that viral persistence and immune dysregulation may play a major role. We performed whole-body positron emission tomography (PET) imaging in a cohort of 24 participants at time points ranging from 27 to 910 days following acute SARS-CoV-2 infection using a novel radiopharmaceutical agent, [(18)F]F-AraG, a highly selective tracer that allows for anatomical quantitation of activated T lymphocytes. Tracer uptake in the post-acute COVID group, which included those with and without Long COVID symptoms, was significantly higher compared to pre-pandemic controls in many anatomical regions, including the brain stem, spinal cord, bone marrow, nasopharyngeal and hilar lymphoid tissue, cardiopulmonary tissues, and gut wall. Although T cell activation tended to be higher in participants imaged closer to the time of the acute illness, tracer uptake was increased in participants imaged up to 2.5 years following SARS-CoV-2 infection. We observed that T cell activation in spinal cord and gut wall was associated with the presence of Long COVID symptoms. In addition, tracer uptake in lung tissue was higher in those with persistent pulmonary symptoms. Notably, increased T cell activation in these tissues was also observed in many individuals without Long COVID. Given the high [(18)F]F-AraG uptake detected in the gut, we obtained colorectal tissue for in situ hybridization SARS-CoV-2 RNA and immunohistochemical studies in a subset of participants with Long COVID symptoms. We identified cellular SARS-CoV-2 RNA in rectosigmoid lamina propria tissue in all these participants, ranging from 158 to 676 days following initial COVID-19 illness, suggesting that tissue viral persistence could be associated with long-term immunological perturbations. Cold Spring Harbor Laboratory 2023-07-31 /pmc/articles/PMC10418298/ /pubmed/37577714 http://dx.doi.org/10.1101/2023.07.27.23293177 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.
spellingShingle Article
Peluso, Michael J.
Ryder, Dylan
Flavell, Robert
Wang, Yingbing
Levi, Jelena
LaFranchi, Brian H.
Deveau, Tyler-Marie
Buck, Amanda M.
Munter, Sadie E.
Asare, Kofi A.
Aslam, Maya
Koch, Wally
Szabo, Gyula
Hoh, Rebecca
Deswal, Monika
Rodriguez, Antonio
Buitrago, Melissa
Tai, Viva
Shrestha, Uttam
Lu, Scott
Goldberg, Sarah A.
Dalhuisen, Thomas
Durstenfeld, Matthew S.
Hsue, Priscilla Y.
Kelly, J. Daniel
Kumar, Nitasha
Martin, Jeffrey N.
Gambir, Aruna
Somsouk, Ma
Seo, Youngho
Deeks, Steven G.
Laszik, Zoltan G.
VanBrocklin, Henry F.
Henrich, Timothy J.
Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19
title Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19
title_full Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19
title_fullStr Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19
title_full_unstemmed Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19
title_short Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19
title_sort multimodal molecular imaging reveals tissue-based t cell activation and viral rna persistence for up to 2 years following covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418298/
https://www.ncbi.nlm.nih.gov/pubmed/37577714
http://dx.doi.org/10.1101/2023.07.27.23293177
work_keys_str_mv AT pelusomichaelj multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT ryderdylan multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT flavellrobert multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT wangyingbing multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT levijelena multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT lafranchibrianh multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT deveautylermarie multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT buckamandam multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT muntersadiee multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT asarekofia multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT aslammaya multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT kochwally multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT szabogyula multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT hohrebecca multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT deswalmonika multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT rodriguezantonio multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT buitragomelissa multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT taiviva multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT shresthauttam multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT luscott multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT goldbergsaraha multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT dalhuisenthomas multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT durstenfeldmatthews multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT hsuepriscillay multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT kellyjdaniel multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT kumarnitasha multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT martinjeffreyn multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT gambiraruna multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT somsoukma multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT seoyoungho multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT deekssteveng multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT laszikzoltang multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT vanbrocklinhenryf multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19
AT henrichtimothyj multimodalmolecularimagingrevealstissuebasedtcellactivationandviralrnapersistenceforupto2yearsfollowingcovid19